Grifols, S.A.
OTC: GIKLY0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Jose Ignacio Abia Buenache
- Employees
- 23,833
- Headquarters
- Barcelona, Spain
- IPO year
- 2010
- Market cap
- $13.3B
- Website
- https://www.grifols.com
Loading GIKLY…
Loading profile data…Frequently asked questions about GIKLY
What does Grifols, S.A. (GIKLY) do?
Grifols, S.A. is a company dedicated to the acquisition, production, processing, and distribution of therapeutic goods, with a primary focus on plasma-derived medicines. Its operations are structured across several key divisions: Bioscience, Hospital, Diagnostic, Bio Supplies, and other segments. The Bioscience unit is responsible for researchin...
Where does GIKLY trade?
Grifols, S.A. (GIKLY) trades on the Other OTC.
What sector is GIKLY in?
Grifols, S.A. (GIKLY) operates in the Healthcare sector, specifically in the Drug Manufacturers - General industry.
Who is the CEO of Grifols, S.A.?
Jose Ignacio Abia Buenache is the chief executive officer of Grifols, S.A. (GIKLY).
Where is Grifols, S.A. headquartered?
Grifols, S.A. is headquartered in Spain.
Does GIKLY pay a dividend?
Yes — Grifols, S.A. (GIKLY) paid a trailing twelve-month dividend of USD 0.09 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did GIKLY go public?
Grifols, S.A. (GIKLY) completed its initial public offering in 2010.
Is GIKLY an ADR?
Yes — GIKLY is an American Depositary Receipt; its underlying shares trade on a non-US exchange. Grifols, S.A. reporting and dividends follow the underlying issuer.